Search - tctmd.com

Displaying 401 - 420 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Presenter: Fernando Alfonso, Stephan Windecker, Juan F. Granada

October 30, 2016

Presentation TCT 2016

Strengths and Limitations of Meta-analysis: Standard, Network and Bayesian Techniques, and the Value of Individual Patient-level Data Pooling

Presenter: Ori Ben-Yehuda, Tullio Palmerini, Giuseppe Biondi-Zoccai

October 30, 2016

Presentation TCT 2016

Bail-out Side Branch Stenting After BVS

Presenter: Francesco Burzotta, Dean J. Kereiakes, Azeem Latib

October 30, 2016

Presentation TCT 2016

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Presenter: Fernando Alfonso, Stephan Windecker, Aloke V. Finn

October 30, 2016

Presentation TCT 2016

Late Bioresorbable Scaffold Malapposition and Aneurysm

Presenter: Teguh Santoso, Wasan Udayachalerm, Jun-Jack Cheng

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Early Insights from Industry

Presenter: Charles J. Davidson, Nicole Ibrahim, Dan Mans

October 30, 2016

Presentation TCT 2016

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Presenter: Fernando Alfonso, Stephan Windecker, Mahesh V Madhavan

October 30, 2016

Presentation TCT 2016

BVS in Bifurcation Lesions: What to Do and What Not to Do

Presenter: Francesco Burzotta, Dean J. Kereiakes, Manuel Pan

October 30, 2016

Presentation TCT 2016

Treatment of In-Stent Restenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most!

Presenter: John A. Bittl, Daniel I. Simon, Salvatore Cassese

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Presenter: Charles J. Davidson, Nicole Ibrahim, Paul Sorajja

October 30, 2016

Presentation TCT 2016

When Are Randomized Trials Not Enough, and Can Observational Data Reliably Inform Comparative Effectiveness Decisions?

Presenter: Eugene H. Blackstone, Robert W. Yeh, Robert A. Harrington

October 30, 2016

Presentation TCT 2016

Treatment of Bifurcation Stenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most!

Presenter: John A. Bittl, Daniel I. Simon, Laura Mauri

October 30, 2016

Presentation TCT 2016

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History!

Presenter: Manel Sabate, Robert-Jan van Geuns, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

Can Propensity and Instrumental Variable Methods Overcome the Limitations of Observational Databases: Lessons From TRANSLATE-ACS

Presenter: Eugene H. Blackstone, Robert W. Yeh, Tracy Y. Wang

October 30, 2016

Presentation TCT 2016

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role!

Presenter: Manel Sabate, Robert-Jan van Geuns, Eric R. Bates

October 30, 2016

Presentation TCT 2016

Comparison of Propensity Score Methods and Covariate Adjustment in Observational Studies: Similarities and Differences

Presenter: Eugene H. Blackstone, Robert W. Yeh, Stuart J. Pocock

October 30, 2016

Presentation TCT 2016

Importance of Unmeasured Confounders in Observational Registries: ASCERT and Other Examples

Presenter: Eugene H. Blackstone, Robert W. Yeh, Kirk N. Garratt

October 30, 2016

Presentation TCT 2016

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? Yes There Are Important Distinctions Relevant to Our Patients!

Presenter: Manel Sabate, Robert-Jan van Geuns

October 30, 2016

Advertisement

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Strengths and Limitations of Meta-analysis: Standard, Network and Bayesian Techniques, and the Value of Individual Patient-level Data Pooling

Bail-out Side Branch Stenting After BVS

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Late Bioresorbable Scaffold Malapposition and Aneurysm

TMVR Clinical Trial Design: Early Insights from Industry

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

BVS in Bifurcation Lesions: What to Do and What Not to Do

Treatment of In-Stent Restenosis

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most!

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

When Are Randomized Trials Not Enough, and Can Observational Data Reliably Inform Comparative Effectiveness Decisions?

Treatment of Bifurcation Stenosis

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most!

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History!

Can Propensity and Instrumental Variable Methods Overcome the Limitations of Observational Databases: Lessons From TRANSLATE-ACS

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role!

Comparison of Propensity Score Methods and Covariate Adjustment in Observational Studies: Similarities and Differences

Importance of Unmeasured Confounders in Observational Registries: ASCERT and Other Examples

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? Yes There Are Important Distinctions Relevant to Our Patients!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content